Stuttgart - Delayed Quote EUR

Argent Biopharma Ltd (H5O0.SG)

Compare
0.1350
+0.0100
+(8.00%)
As of 8:17:40 AM GMT+1. Market Open.
Currency in AUD All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
891.0830
891.0830
3,387.5670
4,732.0120
2,962.8970
Cost of Revenue
687.3860
687.3860
1,936.8900
2,922.1200
1,652.4850
Gross Profit
203.6970
203.6970
1,450.6770
1,809.8920
1,310.4120
Operating Expense
18,465.5180
18,465.5180
17,049.1030
16,071.2870
13,380.3300
Operating Income
-18,261.8210
-18,261.8210
-15,598.4260
-14,261.3950
-12,069.9180
Net Non Operating Interest Income Expense
-480.5450
-480.5450
-257.1630
-209.8410
-361.5030
Other Income Expense
1,193.9330
1,193.9330
-5,275.9280
-6,296.5870
-3,005.1980
Pretax Income
-17,548.4330
-17,548.4330
-21,131.5170
-20,767.8230
-15,436.6190
Tax Provision
--
--
2.0180
--
-27.2780
Net Income Common Stockholders
-17,530.6000
-17,530.6000
-20,823.5830
-20,347.4390
-15,869.9780
Basic EPS
-0.47
--
-7.10
-6.50
-7.30
Diluted EPS
-0.47
--
-7.10
-6.50
-7.30
Basic Average Shares
37,012.4660
--
2,941.1770
2,566.2100
1,906.1140
Diluted Average Shares
37,012.4660
--
2,941.1770
2,566.2100
1,906.1140
Net Income from Continuing & Discontinued Operation
-17,530.6000
-17,530.6000
-20,823.5830
-20,347.4390
-15,869.9780
Normalized Income
-18,364.2180
-18,364.2180
-17,535.5745
-15,197.2580
-11,581.3119
Interest Income
1.9290
1.9290
0.2400
0.3010
7.6320
Interest Expense
482.4740
482.4740
257.4030
210.1420
369.1350
Net Interest Income
-480.5450
-480.5450
-257.1630
-209.8410
-361.5030
EBIT
-17,065.9590
-17,065.9590
-20,874.1140
-20,557.6810
-15,067.4840
EBITDA
-15,772.1640
-15,772.1640
-20,122.1770
-20,309.9920
-14,576.0760
Reconciled Cost of Revenue
687.3860
687.3860
1,936.8900
2,922.1200
1,652.4850
Reconciled Depreciation
1,293.7950
1,293.7950
751.9370
247.6890
491.4080
Net Income from Continuing Operation Net Minority Interest
-17,530.6000
-17,530.6000
-20,823.5830
-20,347.4390
-15,407.3410
Total Unusual Items Excluding Goodwill
833.6180
833.6180
-4,697.1550
-5,150.1810
-3,832.8020
Total Unusual Items
833.6180
833.6180
-4,697.1550
-5,150.1810
-3,832.8020
Normalized EBITDA
-16,605.7820
-16,605.7820
-15,425.0220
-15,159.8110
-10,743.2740
Tax Rate for Calcs
--
--
0.0003
--
0.0000
Tax Effect of Unusual Items
--
--
-1,409.1465
--
-6.7729
6/30/2021 - 3/4/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers